Production of staurosporine derivative using acid isomerization

Details Production of staurosporine derivative using acid isomerization Production of staurosporine derivative using acid isomerization

1999-12-20

2001-03-06

Shah, Mukund J. (Department: 1624)

Organic compounds -- part of the class 532-570 series

Organic compounds

Unsubstituted hydrocarbyl chain between the ring and the -c-...

C540S546000

Reexamination Certificate

active

06197955

ABSTRACT:

BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a process for producing UCN-01 from a solution containing UCN-02 in an efficient and simple manner without complicated steps.
2. Brief Description of the Background Art
UCN-01 is a well-known compound with anti-cancer activity and anti-bacterial activity, having the structure represented by the following formula (II).
The following processes for producing UCN-01 are known:
(1) Japanese Published Unexamined Patent Application 87/220196 provides a fermentation method comprising culturing a microorganism of genus Streptomyces with an ability to generate UCN-01 in a culture medium and harvesting the generated UCN-01;
(2) WO 89/07105 provides a method comprising three-step chemical synthesis of UCN-01 from staurosporine represented by the following formula (III).
Staurosporine is a potent inhibitor of Protein Kinase C and can be readily obtained from Streptomyces sp. Staurosporine is also commercially available, for instance, from Fermentek Corp. of Jerusalem, Israel.
(3) Japanese Published Unexamined Patent Application 94/9645 provides a method comprising oxidizing staurosporine in a solution comprising dimethyl sulfoxide and an aqueous alkali solution to a racemic mixture of UCN-02 represented by the following formula (I):
and a steric isomer thereof, UCN-01 represented by the formula II above, and recovering UCN-01 by column chromatography using a carrier such as a synthetic adsorbent (for example, Diaion HP-20SS manufactured by Mitsubishi Chemical Industries, Co., Ltd.) and silica gel.
However, these methods are disadvantageous in that the culture titer by the fermentation of method (1) is low; the yield of UCN-01 resulting from the chemical synthesis of method (2) is low because 3 steps are required; and the recovery of UCN-01 is low in the column chromatography purification step of method (3) because UCN-02 must be removed as an impurity. Thus, known procedures are very complicated and are not applicable to large scale commercial synthesis.
SUMMARY OF THE INVENTION
The present invention relates to a process for producing UCN-01 in an efficient and simple manner.
More specifically, the present invention provides a process for producing UCN-01, comprising acidifying a solution containing UCN-02 so as to isomerize UCN-02 to UCN-01, and recovering UCN-01 from the resulting acidified solution.
DETAILED DESCRIPTION OF THE INVENTION
The process for producing UCN-01 according to the present invention firstly requires only a solution containing UCN-02. Using such a solution, in conformity with the present invention, highly purified UCN-01 can be produced at an excellent efficiency in a simple manner.
Any solution containing UCN-02 may be used as the solution containing UCN-02 in accordance with the present invention. Suitable solutions containing UCN-02 include, for example, a solution obtained by oxidizing staurosporine in a solution comprising dimethyl sulfoxide and an aqueous alkali solution as discussed in aforementioned Japanese Published Unexamined Patent Application 94/9645.
Solutions containing UCN-02 may contain UCN-01. Therefore, when the solution containing both of UCN-01 and UCN-02, which is obtained by the process for producing UCN-01, is treated by the process of the present invention, the solution containing UCN-01, which consists of both of UCN-01 changed from UCN-02 and UCN-01 existing in the original solution, is obtained, and UCN-01 can be obtained in high yield without separation of UCN-02 from the solutions,
The reaction to isomerize UCN-02 to UCN-01 can be carried out by adding water so that the concentration of water in the solution is preferably 50 v/v % or more, more preferably 90 v/v % or more, and adjusting the solution to preferably pH 5 or less, more preferably pH 1 to 3, further more preferably pH 2 to 2.5.
The concentration of UCN-02 in the reaction mixture is preferably 25 g/L or less, more preferably 5 to 10 g/L. When UCN-01 is contained in the reaction solution, the combined concentration of UCN-01 and UCN-02 in a reaction mixture is adjusted to the aforementioned concentration.
Acids to adjust pH include, among others, acetic acid, hydrochloric acid, sulfuric acid, trifluoroacetic acid, methanesulfonic acid, trifluoromethanesulfonic acid, p-toluenesulfonic acid and xylenesulfonic acid. Further, hydrochloric acid or sulfuric acid is preferably used, and hydrochloric acid is more preferably used.
The reaction temperature is 0 to 50° C., preferably 20 to 30° C.; and the reaction time is 1 to 24 hours.
When the reaction is complete, the reaction mixture is adjusted to pH 7 or more, whereby UCN-01 is precipitated from the reaction mixture. The precipitate of UCN-01 is separated from the reaction mixture in a conventional manner such as a filtration.


REFERENCES:
patent: 4935415 (1990-06-01), Nakano et al.
patent: 5344926 (1994-09-01), Murakata et al.
patent: 0 383 919 (1990-08-01), None
Angewandte Chemie International edition, vol. 38, No. 4 (1999), pp. 549-552.

Affiliated with

Also associated with

Rating

Production of staurosporine derivative using acid isomerization does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Production of staurosporine derivative using acid isomerization, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Production of staurosporine derivative using acid isomerization will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2484888